Association between change in positive airway pressure (PAP) mask type and therapy compliance Source: International Congress 2017 – Efficacy of and compliance with obstructive sleep apnoea treatment Year: 2017
The relationship between lung function and blood glucose control in type 2 diabetic patients Source: Annual Congress 2008 - Lung function, airways and cough Year: 2008
Study of pulmonary function in type2 diabetes mellitus and its changes with change in duration and glycemic control Source: Annual Congress 2012 - Pathophysiological mechanisms in disease: new insights Year: 2012
Effect of CPAP treatment on endothelial function, inflammatory markers, blood pressure and glucose control in patients with OSAS with emphasis on gender differences Source: Annual Congress 2011 - Cardiometabolic and neurocognitive changes in obstructive sleep apnoea Year: 2011
Influence of the glycaemic control [HbA1c] on sleep disorders reported by 261 obese type 2 diabetic patients Source: Annual Congress 2008 - Metabolic syndrome and systemic inflammation in obstructive sleep apnoea Year: 2008
Cheyne-stokes-respiration is an independent modulator of systolic blood pressure in patients with diabetes mellitus type 2 Source: International Congress 2017 – Obstructive and central sleep apnoea: consequences and comorbidities Year: 2017
Long-term continuous positive airway pressure (nCPAP) treatment maintains the improvement of insulin sensitivity in patients with OSAS after 2.8 years Source: Annual Congress 2007 - Treatment options in obstructive sleep apnoea Year: 2007
Insulin therapy increases airway responsiveness in type 2 diabetes patients Source: Annual Congress 2008 - Cough and airway hyperresponsiveness Year: 2008
Decline of the lung function and quality of glycemic control in type 2 diabetes mellitus Source: Annual Congress 2013 –Novel biomarkers and old parameters in clinical management of lung diseases Year: 2013
The effect of continuous positive airway pressure on glucose excursions in diabetics with sleep-disordered breathing: the results of continuous glucose monitoring Source: Eur Respir J 2006; 28: Suppl. 50, 573s Year: 2006
The effect of continuous positive airway pressure on glucose excursions in diabetics with sleep-disordered breathing: the results of continuous glucose monitoring Source: Eur Respir Rev 2006; 15: 218-220 Year: 2006
COPD prevalence and severity is associated to type 2 diabetes mellitus complications and lack of glycometabolic control Source: Annual Congress 2008 - COPD and comorbidities Year: 2008
Antioxidant status in patients with sleep apnoea and impact of continuous positive airway pressure treatment Source: Eur Respir J 2006; 27: 756-760 Year: 2006
Inadequate glucose control in type 2 diabetes is associated with impaired lung function and with systemic inflammation Source: Annual Congress 2009 - Comorbidities and case management in primary respiratory care Year: 2009
Are spirometry indices associated with microvascular complications in type 1 diabetes subjects? Source: International Congress 2019 – Tuberculosis epidemiology, bronchiectasis, other infections and spirometry Year: 2019
Elevated breath glucose is related to respiratory symptoms and not to disease type, control, duration or complications in diabetes mellitus patients Source: Eur Respir J 2007; 30: Suppl. 51, 365s Year: 2007
Effect of ICS on glycaemic control in patients with COPD and comorbid type 2 diabetes: Historical case-matched cohort study Source: International Congress 2016 – Managing multimorbidity and lifestyle change in primary care Year: 2016
3 month continuous positive airway pressure (CPAP) therapy decreases serum lipids, but not homocysteine and leptin concentration in patients with OSAS Source: Annual Congress 2009 - Continuous positive airway pressure therapy in obstructive sleep apnoea Year: 2009
The impact of glycemic control on the treatment outcomes of the patients with pulmonary tuberculosis and DM Source: Annual Congress 2010 - Tuberculosis: metabolic insights Year: 2010
Positive effect of CPAP treatment on the control of difficult-to-treat hypertension Source: Eur Respir J 2007; 29: 951-957 Year: 2007